Celldex Therapeutics Inc. (CLDX)

HEALTH CARE: PHARMACEUTICALS
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

53 FRONTAGE ROAD HAMPTON, NJ 08827

Celldex Therapeutics Inc. develops a portfolio of vaccines against viral and bacterial diseases, including single-dose oral vaccines, a novel, proprietary vaccine candidate for cholesterol management and a treatment to reduce complement-mediated tissue damage associated with cardiac by-pass surgery.

Data as of 2020-08-01
Market Cap399.539 Million Shares Outstanding38.828 Million Avg 30-day Volume1.095 Million
P/E Ratio Dividend Yield EPS-2.91
Price/Sales96.02 Price cash flow ratio Price free cash flow ratio-11.6
Book Value2.16 Price to Tangible Book11.54 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.05859
BETA3.29666 52-week High/Low13.91 / 1.5 Stddev0.585976
View SEC Filings from CLDX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 44 10 (0.65%)
Aggregate 13F shares on 03/31/2020: 3.973 Million 2.977 Million
Aggregate 13F shares on 12/31/2019: 3.968 Million 2.832 Million
Percent change: 0.12% 5.09%
Funds creating new positions: 7 1
Funds Adding to an existing position: 11 5
Funds closing out their position: 8 3
Funds reducing their position: 8
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CLDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CLDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

3.2 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CATLIN AVERY W

  • Director
0 2020-07-15 0

MARINO JAMES J

  • Director
0 2020-07-09 2

CONRAD HERBERT J

  • Director
4,454,566 2020-06-23 1

PEPIN RONALD SR. VP & CBO

  • Officer
0 2020-06-18 1

KELER TIBOR EXECUTIVE VP & CSO

  • Officer
0 2020-06-18 2

MARUCCI ANTHONY S PRESIDENT & CEO

  • Officer
  • Director
0 2020-06-18 2

SHOOS KAREN L.

  • Director
0 2020-06-18 1

PENNER HARRY JR

  • Director
0 2020-06-18 1

WRIGHT RICHARD M. SR. VP & CCO

  • Officer
0 2020-06-18 1

CROWLEY ELIZABETH SR. VP &CPDO

  • Officer
0 2020-06-18 1

CAVANAUGH SARAH SVP OF CORP AFFAIRS & ADMIN.

  • Officer
0 2020-06-18 2

BROWNLIE KEITH L

  • Director
0 2020-06-18 1

MARTIN SAMUEL BATES SVP AND CFO

  • Officer
0 2020-06-18 2

HEATH-CHIOZZI MARGO SVP OF REGULATORY AFFAIRS

  • Officer
0 2020-06-18 2

YOUNG DIANE C. SVP, CHIEF MEDICAL OFFICER

  • Officer
0 2020-06-18 2

SHANNON TIMOTHY M

  • Director
4,569,100 2020-06-17 0

VAN DEN BROEK RICHARD

  • Director
0 2020-06-03 0

DAVIS THOMAS ANDREW CHIEF MEDICAL OFFICER

  • Officer
6,623 2020-06-01 0

ELSTON GEORGE CHIEF FINANCIAL OFFICER

20,000 2020-03-12 0

MCMAHON GERALD PHD PRESIDENT AND CEO

  • Officer
  • Director
0 2020-01-31 0

ELLBERGER LARRY

  • Director
0 2018-06-13 0

LAVALLEE THERESA SVP, REG.& PRECISION MEDICINE

  • Officer
0 2016-12-14 0

MEDAREX INC

  • 10% Owner
No longer subject to file 2014-09-30 0

PAREKH RAJESH R

  • Director
2,000 2010-09-22 0

SCHALLER CHARLES R

  • Director
5,000 2010-09-09 0

NEWBOLD RONALD C SR. VP, BUSINESS DEV.

  • Officer
5,868 2009-01-06 0

PALUCK THOMAS S

  • FORMER 10% OWNER
No longer subject to file 2008-03-07 0

KEILANI TAHA

  • VP MEDICAL & REG AFFAIRS
2,000 2008-01-02 0

FREEMAN PAULA R

  • SR.DIR.HUMAN RESOURCES
2,955 2008-01-02 0

LORANTIS HOLDINGS LTD

  • 10% Owner
0 2007-04-07 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BROWNLIE KEITH L - Director

2020-06-18 A 11,000 a 11,000 0.00 direct

YOUNG DIANE C. - Officer SVP, CHIEF MEDICAL OFFICER

2020-06-18 A 72,000 a 72,000 0.00 direct

CROWLEY ELIZABETH - Officer SR. VP &CPDO

2020-06-18 A 84,000 a 84,000 0.00 direct

MARTIN SAMUEL BATES - Officer SVP AND CFO

2020-06-18 A 105,600 a 105,600 0.00 direct

CONRAD HERBERT J - Director

2020-06-18 A 11,000 a 11,000 0.00 direct

MARUCCI ANTHONY S - Director - Officer PRESIDENT & CEO

2020-06-18 A 245,000 a 245,000 0.00 direct

WRIGHT RICHARD M. - Officer SR. VP & CCO

2020-06-18 A 42,000 a 42,000 0.00 direct

CAVANAUGH SARAH - Officer SVP OF CORP AFFAIRS & ADMIN.

2020-06-18 A 84,000 a 84,000 0.00 direct

PENNER HARRY JR - Director

2020-06-18 A 11,000 a 11,000 0.00 direct

MARINO JAMES J - Director

2020-06-18 A 11,000 a 11,000 0.00 direct

KELER TIBOR - Officer EXECUTIVE VP & CSO

2020-06-18 A 108,000 a 108,000 0.00 direct

PEPIN RONALD - Officer SR. VP & CBO

2020-06-18 A 14,400 a 14,400 0.00 direct

HEATH-CHIOZZI MARGO - Officer SVP OF REGULATORY AFFAIRS

2020-06-18 A 84,000 a 84,000 0.00 direct

SHOOS KAREN L. - Director

2020-06-18 A 11,000 a 11,000 0.00 direct

YOUNG DIANE C. - Officer SVP, CHIEF MEDICAL OFFICER

2020-06-11 P 2,115 $4.73 a 2,115 2,115.00 direct

CAVANAUGH SARAH - Officer SVP OF CORP AFFAIRS & ADMIN.

2020-06-10 P 1,050 $4.83 a 1,367 1,367.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Celldex Therapeutics Inc. 1.28% 2019-11-12 GERMANY
Squarepoint Ops LLC Celldex Therapeutics Inc. 0.79% 2019-12-18 GERMANY
Squarepoint Ops LLC Celldex Therapeutics Inc. 1.08% 2019-11-25 GERMANY
Squarepoint Ops LLC Celldex Therapeutics Inc. 0.68% 2019-12-31 GERMANY
Squarepoint Ops LLC Celldex Therapeutics Inc. 1.17% 2019-11-19 GERMANY
Squarepoint Ops LLC Celldex Therapeutics Inc. 0.99% 2019-12-02 GERMANY
Squarepoint Ops LLC Celldex Therapeutics Inc. 0.87% 2019-12-10 GERMANY
Squarepoint Ops LLC Celldex Therapeutics Inc. 0.59% 2020-01-14 GERMANY

Elevate your investments